Is CYP1A1 induction always related to AHR signaling pathway?

被引:121
作者
Delescluse, C [1 ]
Lemaire, G [1 ]
de Sousa, G [1 ]
Rahmani, R [1 ]
机构
[1] INRA, Ctr Rech, Lab Pharmaco Toxicol Cellulaire & Mol, F-06606 Antibes, France
关键词
exogenous compounds; cytochrome P450s; CYP1A1; regulation;
D O I
10.1016/S0300-483X(00)00305-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Humans are daily subjected to ever increasing amounts of exogenous compounds. Some of them are capable of inducing cytochrome P450s, a process that allows the cell to adapt to changes in its chemical environment. One of the most widely CYP studied is CYP1A1 because it metabolises a large number of xenobiotics to cytotoxic and/or mutagenic derivatives. To date, results from the literature indicate that induction of CYP1A1 does not only involve the classical activation cascade of the Ah receptor, e.g. binding of the ligand to the AhR, heterodimerisation with Amt protein, constitution of a complex with XRE responsive element and subsequent gene activation. Indeed, some xenobiotics do activate CYP1A1 gene expression in spite of their inability to compete with TCDD for binding to the AhR. Other signaling pathways must therefore also be considered. Firstly, the CYP1A1 inducer compounds could be very weak AhR ligands or may be metabolized into a form which is in turn capable of binding to the Ah receptor. A second hypothesis would be that these molecules could act through other signaling cascades. At this time, two of them seem to be implicated. One concerns the RARs signal transduction pathway, as already described for retinoic acid. The second may involve tyrosine kinase activation, but the precise relationship between this activation and CYPA1 induction remains yet to be established. For the moment there is still a black box which needs to be investigated. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:73 / 82
页数:10
相关论文
共 44 条
  • [11] FILVAROFF E, 1994, J BIOL CHEM, V269, P21735
  • [12] Cytochrome 1A1 induction by primaquine in human hepatocytes and HepG2 cells: Absence of binding to the aryl hydrocarbon receptor
    Fontaine, F
    Delescluse, C
    de Sousa, G
    Lesca, P
    Rahmani, R
    [J]. BIOCHEMICAL PHARMACOLOGY, 1999, 57 (03) : 255 - 262
  • [13] FONTAINE F, 1998, ADV MOL TOX, P359
  • [14] GASIEWICZ TA, 1991, MOL PHARMACOL, V40, P607
  • [15] A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein - Linking dioxin signaling to the cell cycle
    Ge, NL
    Elferink, CJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (35) : 22708 - 22713
  • [16] Ah receptor-dependent CYP1A induction by two carotenoids, canthaxanthin and beta-apo-8'-carotenal, with no affinity for the TCDD binding site
    Gradelet, S
    Astorg, P
    Pineau, T
    Canivenc, MC
    Siess, MH
    Leclerc, J
    Lesca, P
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 54 (02) : 307 - 315
  • [17] GRADIN K, 1994, J BIOL CHEM, V269, P23800
  • [18] EXPRESSION OF AH RECEPTOR (TCDD RECEPTOR) DURING HUMAN MONOCYTIC DIFFERENTIATION
    HAYASHI, S
    OKABEKADO, J
    HONMA, Y
    KAWAJIRI, K
    [J]. CARCINOGENESIS, 1995, 16 (06) : 1403 - 1409
  • [19] SHEEP LUNG CYTOCHROME P4501A1 (CYP1A1) - CDNA CLONING AND TRANSCRIPTIONAL REGULATION BY OXYGEN-TENSION
    HAZINSKI, TA
    NOISIN, E
    HAMON, I
    DEMATTEO, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) : 2083 - 2089
  • [20] Induction of cytochrome P-450 1A1 by omeprazole in human HepG2 cells is protein tyrosine kinase-dependent and is not inhibited by α-naphthoflavone
    Kikuchi, H
    Hossain, A
    Yoshida, H
    Kobayashi, S
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 358 (02) : 351 - 358